MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical profile and treatment response patterns in patients of Truncal Dystonia: A retrospective case series from a tertiary care hospital in India

S. Mehta, S. Ray, V. Lal (Chandigarh, India)

Meeting: 2019 International Congress

Abstract Number: 1314

Keywords: Botulinum toxin: Clinical applications: dystonia, Dystonia: Clinical features, Dystonia: Treatment

Session Information

Date: Tuesday, September 24, 2019

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To identify the clinical profile and treatment response patterns in patients with truncal dystonia.

Background: Truncal Dystonia is characterized by involuntary contractions and postures of the paraspinal, abdominal and chest muscles. Presence of truncal dystonia usually points to a secondary cause for dystonia like exposure to dopamine receptor blockers or neurodegenerative illness. Rarely, it can occur as an idiopathic focal or segmental dystonia.

Method: Retrospective review of medical records and videos of patients of truncal dystonia in our registry from May 2016 to February 2019.

Results: A total of 14 patients (out of more than 500 patients of dystonia treated with botulinum toxin) with predominant truncal dystonia were found. There were nine males and five females with mean age of 52 years (range 33-70). Extensor truncal dystonia was most common (10/14) followed by camptocormia (4/14).The various etiologies included Idiopathic Parkinson’s disease (4/14), Tardive (3/14), Neurodegeneration with brain iron accumulation (genetically confirmed) (2/14) or idiopathic (5/14) in nature. All patients except one were refractory to a combination of oral medications tried over a minimum period of six months. Suboptimal relief was the most common indication for Botulinum toxin injection. 13 patients received electromyographic guided botulinum toxin in the involved muscles (lumbar paraspinals, rectus abdominis, pectoralis as indicated) and showed modest response over medications. Mean dose of abobotulinum toxin used was 500 units.

Conclusion: Truncal dystonia is a relatively rare presentation. It can be involved as an isolated dystonia or with involvement of other body regions. It is usually refractory to multiple oral medications but may show modest benefit with botulinum toxin injections.

References: 1. Comella, C. L., Shannon, K. M. and Jaglin, J. (1998), Extensor truncal dystonia: Successful treatment with botulinum toxin injections. Mov. Disord., 13: 552-555. 2. Ehrlich DJ, Frucht SJ. The phenomenology and treatment of idiopathic adult-onset truncal dystonia: A retrospective review. J Clin Mov Disord 2016;3:15.

To cite this abstract in AMA style:

S. Mehta, S. Ray, V. Lal. Clinical profile and treatment response patterns in patients of Truncal Dystonia: A retrospective case series from a tertiary care hospital in India [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-profile-and-treatment-response-patterns-in-patients-of-truncal-dystonia-a-retrospective-case-series-from-a-tertiary-care-hospital-in-india/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-profile-and-treatment-response-patterns-in-patients-of-truncal-dystonia-a-retrospective-case-series-from-a-tertiary-care-hospital-in-india/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley